| Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery H Lee, AKR Lytton-Jean, Y Chen, KT Love, AI Park, ED Karagiannis, ... Nature nanotechnology 7 (6), 389-393, 2012 | 1153 | 2012 |
| Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling G Sahay, W Querbes, C Alabi, A Eltoukhy, S Sarkar, C Zurenko, ... Nature biotechnology 31 (7), 653-658, 2013 | 769 | 2013 |
| Multiscale models of angiogenesis AA Qutub, F Mac Gabhann, ED Karagiannis, P Vempati, AS Popel IEEE engineering in medicine and biology magazine 28 (2), 14-31, 2009 | 190 | 2009 |
| The influence of scaffold elasticity on germ layer specification of human embryonic stem cells J Zoldan, ED Karagiannis, CY Lee, DG Anderson, R Langer, S Levenberg Biomaterials 32 (36), 9612-9621, 2011 | 172 | 2011 |
| Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing E Laks, A McPherson, H Zahn, D Lai, A Steif, J Brimhall, J Biele, B Wang, ... Cell 179 (5), 1207-1221. e22, 2019 | 161 | 2019 |
| A biochemical model of matrix metalloproteinase 9 activation and inhibition P Vempati, ED Karagiannis, AS Popel Journal of Biological Chemistry 282 (52), 37585-37596, 2007 | 107 | 2007 |
| A Theoretical Model of Type I Collagen Proteolysis by Matrix Metalloproteinase (MMP) 2 and Membrane Type 1 MMP in the Presence of Tissue Inhibitor of Metalloproteinase 2*[boxs] ED Karagiannis, AS Popel Journal of Biological Chemistry 279 (37), 39105-39114, 2004 | 99 | 2004 |
| Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a … ED Karagiannis, AS Popel Journal of theoretical biology 238 (1), 124-145, 2006 | 93 | 2006 |
| A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells ED Karagiannis, AS Popel Proceedings of the National Academy of Sciences 105 (37), 13775-13780, 2008 | 88 | 2008 |
| Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 … JE Koskimaki, ED Karagiannis, EV Rosca, F Vesuna, PT Winnard Jr, ... Neoplasia 11 (12), 1285-IN2, 2009 | 81 | 2009 |
| Identification of novel short peptides derived from the α4, α5, and α6 fibrils of type IV collagen with anti-angiogenic properties ED Karagiannis, AS Popel Biochemical and biophysical research communications 354 (2), 434-439, 2007 | 77 | 2007 |
| Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model JE Koskimaki, ED Karagiannis, BC Tang, H Hammers, DN Watkins, R Pili, ... BMC cancer 10, 1-7, 2010 | 60 | 2010 |
| Rational design of a biomimetic cell penetrating peptide library ED Karagiannis, AM Urbanska, G Sahay, JM Pelet, S Jhunjhunwala, ... Acs Nano 7 (10), 8616-8626, 2013 | 54 | 2013 |
| Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer AM Urbanska, ED Karagiannis, G Guajardo, RS Langer, DG Anderson Biomaterials 33 (18), 4752-4761, 2012 | 53 | 2012 |
| Expansion microscopy: development and neuroscience applications ED Karagiannis, ES Boyden Current opinion in neurobiology 50, 56-63, 2018 | 49 | 2018 |
| Directing human embryonic stem cell differentiation by non-viral delivery of siRNA in 3D culture J Zoldan, AKR Lytton-Jean, ED Karagiannis, K Deiorio-Haggar, LM Bellan, ... Biomaterials 32 (31), 7793-7800, 2011 | 46 | 2011 |
| Compositions having antiangiogenic activity and uses thereof AS Popel, ED Karagiannis US Patent 8,557,772, 2013 | 45 | 2013 |
| Expansion microscopy of lipid membranes ED Karagiannis, JS Kang, TW Shin, A Emenari, S Asano, L Lin, EK Costa, ... BioRxiv, 829903, 2019 | 43 | 2019 |
| Peptide modulators of angiogenesis and use thereof AS Popel, ED Karagiannis US Patent 8,507,434, 2013 | 32 | 2013 |
| Anti-angiogenic peptides identified in thrombospondin type I domains ED Karagiannis, AS Popel Biochemical and biophysical research communications 359 (1), 63-69, 2007 | 32 | 2007 |
Aleksander S. PopelProfessor of Biomedical Engineering, Johns Hopkins University, School of MedicineVerified email at jhu.edu
